The reaction was initiated by the addition of 0.5 units of GR, and changes in the absorbance were monitored at 412 nm for 1 min in a microplate reader
BPC-157 is not FDA-approved, so it cannot be legally prescribed or dispensed by any licensed healthcare provider
In women, OS is implicated in various reproductive disorders, including polycystic ovary syndrome, endometriosis, and premature ovarian failure, leading to diminished oocyte quality, disrupted folliculogenesis, and poorer reproductive outcomes
No published trial preclinical or human has tested BPC-157 + TB-500 together
Shiro Pharmaceutical & Co., Japan
Front Physiol (2015) 6:109